Related Experiment Video
Updated: Aug 9, 2026
08:05
Electrophysiological Methods to Assess Peripheral Pain Block in an Anesthetized Rat
Published on: November 21, 2025
Therapeutic efficacy of facet joint blocks
Christoph Gorbach1, Marius R Schmid, Achim Elfering
1Center for Spinal Surgery, University of Zurich, University Hospital Balgrist, Zurich, Switzerland.
AJR. American Journal of Roentgenology
|April 25, 2006
Summary
Facet joint blocks offer medium-term pain relief for about a third of chronic lower back pain patients. Clinical factors, not imaging, predict successful outcomes for these therapeutic injections.
Area of Science:
- Pain Medicine
- Interventional Radiology
- Spinal Surgery
Background:
- Facet joint blocks are utilized for chronic lower back pain management.
- Predicting the therapeutic efficacy of these blocks remains a clinical challenge.
Purpose of the Study:
- To identify predictors for short- and medium-term therapeutic efficacy of facet joint blocks in patients with chronic lower back pain.
Main Methods:
- Retrospective analysis of 42 patients undergoing facet joint blocks.
- Assessment of pain response using visual analogue scale and telephone interviews.
- Correlation of clinical factors and imaging findings (MRI/CT) with treatment outcomes.
Main Results:
- A positive immediate effect was observed in 74% of patients.
- A medium-term positive effect was noted in 33% of patients.
- Pain relief was predicted by pain alleviation with motion and absence of joint-blocking sensation; imaging findings were not significant predictors.
Conclusions:
- Facet joint blocks provide a beneficial medium-term effect in a subset of chronic lower back pain patients.
- Clinical presentation, rather than morphologic imaging findings, appears to be the key determinant of treatment success.
- Facet joint blocks can be a valuable adjunct to nonoperative pain management strategies.
Related Concept Videos
01:30Local Anesthetics: Clinical Application as Surface, Infiltration, and Conduction Block Anesthesia
Depending on the target organ, local anesthetics (LAs) can be administered via various routes. In surface anesthesia, LAs are applied directly to the surface of the skin or mucous membranes. It is widely used for topical skin numbing before venipuncture or minor surgical procedures. Commonly used surface local anesthetics are lidocaine or benzocaine sprays or creams. Surface anesthesia occurs within 5 minutes and lasts for about 60 minutes. One of the main disadvantages of topical anesthesia is...
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
01:24Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
01:09Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs,...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs,...
01:17Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...